Screener
CRISPR Therapeutics CRSP Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by CRISPR Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: CRISPR Therapeutics’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:48 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204188
| Line item | As of / March 31, 2026 | As of / December 31, 2025 |
|---|---|---|
| Total liabilities | 911,264 | 343,430 |
| Commitments and contingencies, see Note 7 | ||
| Shareholders’ equity: | ||
| Common shares, CHF 0.03 nominal value, 132,477,166 shares authorized at March 31, 2026 and at December 31, 2025, 96,500,822 and 96,009,657 shares issued at March 31, 2026 and December 31, 2025, respectively, 96,385,506 and 95,894,341 shares outstanding at March 31, 2026 and December 31, 2025, respectively | 3,115 | 3,087 |
| Treasury shares, at cost, 115,316 shares at March 31, 2026 and at December 31, 2025 | (60) | (60) |
| Additional paid-in capital | 3,883,924 | 3,861,516 |
| Accumulated deficit | (2,070,482) | (1,947,551) |
| Accumulated other comprehensive (loss) income | (1,941) | 4,821 |
Item 1. Financial Statements
FAQ
- What is CRISPR Therapeutics's common stock?
- CRISPR Therapeutics (CRSP) reported common stock of $3.12M in Q1 2026.
- How has CRISPR Therapeutics's common stock changed year-over-year?
- CRISPR Therapeutics's common stock increased by 14.5% year-over-year, from $2.72M to $3.12M.
- What is the long-term trend for CRISPR Therapeutics's common stock?
- Over 5 years (2020 to 2025), CRISPR Therapeutics's common stock has grown at a 6.3% compound annual growth rate (CAGR), from $2.28M to $3.09M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about CRISPR Therapeutics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude